Nasalferon, a new nasal formulation of IFNα2b, modulates cellular and molecular elements associated with an antiviral response in mucosa and bloodDania Vázquez‐Blomquist, Gerardo Guillén, Mónica Béquet‐Romero et al.|Clinical Immunology Communications|2022Cited by 5
El péptido liberador de la Hormona de Crecimiento-6 (GHRP6) reduce la fibrosis del hígado en ratas intoxicadas crónicamente con CCl4Jorge Berlanga‐Acosta, Gerardo Guillén, Dania Vázquez‐Blomquist et al.|Biotecnología aplicada|2012Cited by 2
A combination treatment of IFN-α2b and IFN-γ accelerates viral clearance and control inflammatory response in COVID-19: Preliminary results of a randomized controlled trialIdelsis Esquivel-Moynelo, Iraldo Bello Rivero, Mónica Béquet‐Romero et al.|Annals of Antivirals and Antiretrovirals|2021Cited by 2
GHRP-6, a novel candidate for prevention and treatment of fibrotic disordersYssel Mendoza‐Marí, Jorge Berlanga‐Acosta, Maday Fernández‐Mayola et al.|DOAJ (DOAJ: Directory of Open Access Journals)|2017Cited by 1
Pharmacodynamic of Recombinant Human Interferon Alpha-2b Nasal Drops and Effective Prophylaxis Against SARS-COV-2 InfectionHugo Nodarse-Cuní, Ileana Morales, Odalys Bravo et al.|Journal of Interferon & Cytokine Research|2024Cited by 1